The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.